Clinical Trials Browser

Withdrawn × Interventional × Klatskin Tumor × Clear all

NCT03353181 2022-08-25

ENBD

Phase NA Withdrawn

Gastrointestinal

Klatskin Tumor

NCT02856568 2017-05-30

Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma

Phase 1 Withdrawn

Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor